•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Bausch + Lomb Corporation (BLCO) Receives a Buy from Wells Fargo
Bausch + Lomb Unveils New Daily Astigmatism Lenses
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
Bausch + Lomb Debuts Nutritional Dry Eye Relief
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Buy Rating Affirmed: Bausch + Lomb’s Strong Product Sales and Market Position Drive Positive Outlook
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
Bausch + Lomb Showcases Eye Care Innovations
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting®
Bausch + Lomb’s New Vision-Correcting Lens Approved
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
Stocks making the biggest moves midday: Berkshire Hathaway, Micron, Tyson Foods, Spirit Airlines and more
Morgan Stanley upgrades Bausch + Lomb, cites improving margins
Jim Cramer's top 10 things to watch in the stock market Monday
Here are Monday's biggest analyst calls: Nvidia, Apple, Amazon, U.S. Steel, Micron, Disney, Citi & more
Stocks making the biggest premarket moves: Berkshire Hathaway, Paramount, Spirit Air, Victoria's Secret and more
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
Bausch + Lomb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)
The market rallied but not our stocks that reported earnings — so we pounced on 2 of them
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.